SEATTLE, May 31, 2011 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced
today that Robert Kirkman, M.D., President and Chief Executive Officer,
will present at the Jefferies 2011 Global Healthcare Conference in New
York on Monday, June 6, 2011, at 8:30 a.m. Eastern Time.
A live and archived webcast of Dr. Kirkman's presentation will be
accessible by visiting the Oncothyreon website www.oncothyreon.com under the "News & Events" section.
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development
of innovative therapeutic products for the treatment of cancer.
Oncothyreon's goal is to develop and commercialize novel synthetic
vaccines and targeted small molecules that have the potential to
improve the lives and outcomes of cancer patients. For more
information, visit www.oncothyreon.com.
SOURCE Oncothyreon Inc.
